中国药物警戒 ›› 2010, Vol. 7 ›› Issue (2): 97-99.

• 管理研究 • 上一篇    下一篇

我国药品不良反应救济体系建立的探讨

龙项1,2,3, 周志宏2, 冯默2, 吴小红2, 彭六保3*   

  1. 1岳阳市二人民医院药剂科,湖南 岳阳414000;
    2岳阳市药学会,湖南岳阳 414000;
    3中南大学药学院,湖南 长沙410011
  • 收稿日期:2016-02-19 修回日期:2016-02-19 出版日期:2010-02-08 发布日期:2016-02-19
  • 通讯作者: 彭六保,女,博士生导师,药事管理与药物经济学。
  • 作者简介:龙项,男,主管药师,医院临床药学与药物经济学。

Research on Establishment of Averse Drug Reactions Relief System in China

LONG Xiang1,2,3, ZHOU Zhi-hong2, FENG Mo2, WU Xiao-hong2, PENG Liu-bao3,*   

  1. 1Department of harmacy,Yueyang second People's Hospital, Hunan Yueyang 414000,China;
    2Pharmaceutical Society of Yueyang, Hunan Yueyang 414000,China;
    3College of Pharmacy, Central South University, Hunan Changsha 410011, China
  • Received:2016-02-19 Revised:2016-02-19 Online:2010-02-08 Published:2016-02-19

摘要: 目的 提出构建我国药品不良反应救济体系的若干设想,建立我国药品不良反应救济制度。方法 从药品不良反应的归属判别、救济范围与形式、基金管理、法律依据等方面进行探讨,以构建我国的药品不良反应救济体系。结果结论 药源性危害不可避免,造成损害理应给予受害人适当的救济,依据我国国情,构建我国的药品不良反应救济体系是可行的。

关键词: 药品不良反应, 救济

Abstract: Objective To construct adverse drug reaction(ADR) system in China. Methods The attribution of ADR discrimination, the scope and form of relief, fund management, and other aspects of the legal basis was probed to build our country's ADR relief system. Results &Conclusion drug-induced harm is inevitable, causing damage to the victim should be given to appropriate relief, according to our national conditions, to build ADR relief system is feasible in china.

Key words: adverse drug reaction, relief

中图分类号: